PackGene Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Series C1
- Latest Deal Amount
-
$13.9M
- Investors
-
14
PackGene General Information
Description
Developer and researcher of clinical-grade recombinant adeno-associated virus designed to promote the growth of genetic medicines. The company focuses on the rapid and large-scale production of purity, titer, infectivity, and preclinical and clinical-grade recombinant adeno-associated virus (AAV), and provides AAV and lentivirus customized packaging, vector cloning, and other services, enabling medical industry researchers to accelerate gene therapy programs with scalable and cost-effective options.
Contact Information
Website
www.packgene.comCorporate Office
- 9310 Kirby Drive
- Suite 900
- Houston, TX 77054
- United States
Corporate Office
- 9310 Kirby Drive
- Suite 900
- Houston, TX 77054
- United States
PackGene Timeline
PackGene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series C1) | 01-Dec-2023 | $13.9M | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series C) | 18-Apr-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 01-Mar-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B1) | 26-Oct-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 12-Aug-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 01-Feb-2020 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 2. Later Stage VC | 01-Jul-2019 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
PackGene Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PackGene Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PackGene Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| SDIC Capital Management | Growth/Expansion | Minority | ||
| GDD Industry Fund | Government | Minority | ||
| Guangzhou Fund | Government | Minority | ||
| Guangzhou Yuegang Fund Management | Growth/Expansion | Minority | ||
| Sanmei Investment | Growth/Expansion | Minority |
PackGene FAQs
-
When was PackGene founded?
PackGene was founded in 2014.
-
Where is PackGene headquartered?
PackGene is headquartered in Houston, TX.
-
What is the size of PackGene?
PackGene has 40 total employees.
-
What industry is PackGene in?
PackGene’s primary industry is Laboratory Services (Healthcare).
-
Is PackGene a private or public company?
PackGene is a Private company.
-
What is PackGene’s current revenue?
The current revenue for PackGene is .
-
How much funding has PackGene raised over time?
PackGene has raised $30.1M.
-
Who are PackGene’s investors?
SDIC Capital Management, GDD Industry Fund, Guangzhou Fund, Guangzhou Yuegang Fund Management, and Sanmei Investment are 5 of 14 investors who have invested in PackGene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
